Figure 5. Dose curve of recombinant PRKCzeta on PKCzeta activity. Quiescent REC were treated with indicated doses of PRKCzeta in high-glucose conditions and analyzed by western blotting for phosphorylated PKCzeta/PKCzeta ratios. *p<0.05 versus HG control. n=3. Data are mean ± SEM.